Supraventricular Arrhythmias

Published on 26/03/2015 by admin

Filed under Critical Care Medicine

Last modified 26/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3389 times

78 Supraventricular Arrhythmias

image Classification and Epidemiology

Supraventricular arrhythmias include rhythms arising from the sinus node and the adjacent atrial tissue (inappropriate sinus tachycardia, sinoatrial reentry tachycardia), both the right and left atria (atrial tachycardia, flutter, and fibrillation), the atrioventricular (AV) node (AV nodal reentry tachycardia, accelerated ectopic junctional rhythm), and the AV node, with involvement of an accessory pathway or multiple pathways (AV reentry tachycardia) (Figure 78-1).

Atrial Flutter and Fibrillation

Atrial fibrillation is the most common supraventricular arrhythmia, affecting 1% to 2% of the general population, especially the elderly. It is usually associated with cardiovascular pathologies, among which hypertension and congestive heart failure prevail.2 About a third of patients, however, present with no underlying heart disease and are considered to have “lone” atrial fibrillation. The epidemiology of isolated atrial flutter is largely unknown and is believed to be in the range of 0.037% to 0.88% per 1000 person-years, but at least half these patients also have atrial fibrillation as a coexistent arrhythmia.

image Clinical Presentation

The leading symptom of most supraventricular tachyarrhythmias, particularly AV nodal reentry tachycardia and AV reentry tachycardia, is rapid, regular palpitations, usually with an abrupt onset; they can occur spontaneously or be precipitated by simple movements. A common feature of tachycardias that involve circulation through the AV node is termination by the Valsalva maneuver. In younger individuals with no structural heart disease, the rapid heart rate can be the main pathologic finding. Other symptoms may include anxiety, dizziness, dyspnea, neck pulsation, central chest pain, weakness, and occasionally polyuria due to the release of atrial natriuretic peptide in response to increased atrial pressures (more common in atrial tachycardia and AV nodal reentry tachycardia). Prominent jugular venous pulsations due to atrial contractions against closed AV valves may be observed during AV nodal reentry or AV reentry tachycardia.

True syncope is relatively uncommon unless uncontrolled tachycardia over 200 beats per minute is sustained for a long period, especially in patients who remain standing. Syncope has been reported in 10% to 15% of patients, usually just after onset of the arrhythmia or in association with a prolonged pause following its termination. However, in older patients with concomitant heart disease such as aortic stenosis, hypertrophic cardiomyopathy, and cerebrovascular disease, significant hypotension and syncope may result from profound hemodynamic collapse associated with only moderately fast ventricular rates.

It is essential to recognize that patients presenting with AV reentry tachycardia may also present with atrial fibrillation. If an accessory pathway has a short antegrade effective refractory period (<250 msec), it may conduct to the ventricles at an extremely high rate and cause ventricular fibrillation. The incidence of sudden death is 0.15% to 0.39% per patient-year, and it may be the first manifestation of the disease in younger individuals.

Irregular palpitations may be due to atrial premature beats, atrial flutter with varying AV conduction block, atrial fibrillation, or multifocal atrial tachycardia. Although highly symptomatic, these arrhythmias usually have a benign hemodynamic prognosis. However, in patients with depressed ventricular function, uncontrolled atrial fibrillation can reduce cardiac output and precipitate hypotension and congestive heart failure. Atrial fibrillation in association with slow AV conduction or complete block (Frederick’s syndrome) may result in hemodynamic collapse. Inappropriate sinus tachycardia and nonparoxysmal accelerated junctional rhythm are characterized by relatively slow heart rates and gradual onset and termination.

image Electrocardiography

Whenever possible, a 12-lead electrocardiogram (ECG) should be taken during tachycardia. If a patient with an arrhythmia is hemodynamically unstable, a monitor strip should be obtained from the defibrillator before electrical discharge.

image Atrioventricular Nodal Reentry Tachycardia

Electrocardiographic Presentation

In sinus rhythm, the ECG is usually normal unless other unrelated abnormalities are present. During AV nodal reentry tachycardia, the rhythm is regular, with narrow QRS complexes and a rate of 140 to 250 beats per minute. The atria are activated retrogradely, producing the inverted P waves in leads II, III, and aVF. Because atrial and ventricular depolarization occurs simultaneously, the P waves are often obscured by the QRS complexes and cannot be detected on the surface ECG (Figure 78-4, A). However, in about a third of cases of slow-fast AV nodal reentry tachycardia, a terminal positive deflection in lead aVR or V1 (or both), imitating right bundle branch block or pseudo-S waves in the inferiorly oriented leads, may be present, reflecting retrograde activation of the atria. Tachycardia using these pathways in reverse (“fast-slow,” or long RP, tachycardia) is less common (5%-10% of cases).

image Atrioventricular Reentry Tachycardia

Mechanism and Electrocardiographic Presentation

The reentry circuit of orthodromic AV reentry tachycardia involves the AV node and an accessory pathway, with the impulses conducting from the atria to the ventricles over the AV node and traveling in the reverse direction through the accessory pathway (see Figure 78-4, B). In antidromic AV reentry tachycardia, the reentrant impulses conduct antegradely from the atria to the ventricles via an accessory pathway and retrogradely via the AV node or a second accessory pathway (see Figure 78-4, C). Antidromic AV reentry tachycardia is uncommon (<10% of cases). Atrial fibrillation is usually encountered in patients with antegradely conducting pathways (see Figure 78-4, D).

Acute Management

In an emergency, distinguishing between AV nodal reentry tachycardia and AV reentry tachycardia may be difficult, but it is usually not critical, because both tachycardias respond to the same treatment. If the patient is hemodynamically stable, vagal maneuvers including carotid sinus massage, Valsalva maneuver, and facial immersion in cold water (diving reflex) can terminate tachycardia in about 50% of patients (Box 78-1).3,4 Commercially available gel packs can be used as cold compresses instead of facial immersion, but the most important element is wet nostrils and breath-holding.

Box 78-1

Vagal Maneuvers to Terminate Tachycardia

Pharmacologic Termination

AV blocking agents such as adenosine, verapamil, diltiazem, and beta-blockers are effective in terminating both AV nodal reentry and AV reentry tachycardia (Table 78-1).1

Adenosine

Intravenous (IV) adenosine is effective in diagnosing, rate slowing, and often terminating narrow-complex tachycardias.5 Adenosine usually terminates AV nodal reentry tachycardia and AV reentry tachycardia but rarely interrupts the atrial flutter circuit and does not suppress automatic atrial tachycardia; it can, however, produce high-degree AV block during which the tachycardia persists (Figure 78-5). It has no effect on most ventricular tachycardias. Adenosine is advantageous compared with verapamil because of its rapid onset and the absence of a negative inotropic effect in patients with poor left ventricular function and those with significant hypotension.

Buy Membership for Critical Care Medicine Category to continue reading. Learn more here